Researchers have captured the first three-dimensional structure of the malaria parasite's "moving junction" — the ring-shaped gateway it builds to force its way into red blood cells. The breakthrough, reported in a study highlighted by Genetic Engineering News, reveals that this structure is not a passive tunnel but an active machine that remodels the host cell membrane from within.
The moving junction is formed by parasite proteins that latch onto the red blood cell surface and cinch tight, creating a conduit for invasion. The new structural data shows the junction physically reshapes the host membrane, a process previously invisible to scientists. Critically, the study also demonstrated that synthetic binders targeting this junction can block the parasite from entering cells altogether.
This discovery opens a new front against a pathogen that infects over 200 million people annually. The moving junction is essential for all species of Plasmodium, the parasite genus that causes malaria, meaning a drug designed to jam this structure could work against multiple strains, including drug-resistant ones.
The work was done by an international team using cryo-electron microscopy, yielding a near-atomic-resolution model. The researchers plan to use this structure as a template for designing small molecules or antibodies that could serve as next-generation antimalarials.
While the structural findings are a major leap, a therapeutic remains years away. The junction is a complex, multiprotein assembly; any drug candidate will need to survive rigorous safety and efficacy testing in animal models before entering human trials. The parasite's evolutionary cleverness means it may eventually find a workaround, but for now, scientists have their clearest target yet.